国家医保局:医药机构欺诈骗保将被解除定点协议

2018-12-01 张泉 新华网

国家医保局日前印发《关于当前加强医保协议管理确保基金安全有关工作的通知》,要求各地医保经办机构加强对定点医药机构的协议管理,确保医保基金安全。

国家医保局日前印发《关于当前加强医保协议管理确保基金安全有关工作的通知》,要求各地医保经办机构加强对定点医药机构的协议管理,确保医保基金安全。

通知明确,定点医药机构发生欺诈骗保等违约行为的,一律解除服务协议,被解除服务协议的定点医药机构,3年内不得申请医保定点;对查实具有骗取医保基金等违规行为的医师,给予停止1-5年医保结算资格的处理;对具有骗取医保基金或倒卖药品等违规行为的参保人,可给予暂停医保直接结算等处理。

通知要求,各地医保经办机构进一步完善和细化协议内容,加强对医药机构申报材料和信息的审核,对定点医药机构申报的费用建立规范的初审、复审两级审核机制,加强对定点医药机构履行协议情况的监督检查。

据介绍,医保经办机构与定点机构签订的服务协议,是医保基金监管的主要手段之一。通过加强协议管理,强化协议约束力,让违反协议的机构付出代价,将对欺诈骗保行为产生有力震慑,并推动构建打击欺诈骗保行为的长效机制。

此前,国家医保局部署了打击欺诈骗取医疗保障基金专项行动“回头看”,开通了举报投诉电话和微信举报通道,制定了举报奖励机制,鼓励公民、法人或其他社会组织对医保经办机构工作人员,定点医疗机构、定点零售药店及其工作人员以及参保人员等涉嫌欺诈骗保的行为进行举报,并对查证属实线索的举报人给予奖励。通过一系列“组合拳”,对欺诈骗保行为保持高压态势。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719706, encodeId=d85e1e1970687, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Sun Jun 09 11:35:00 CST 2019, time=2019-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280448, encodeId=9b511280448eb, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409736, encodeId=5dfc1409e3622, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497206, encodeId=4142149e20631, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587175, encodeId=a386158e17502, content=<a href='/topic/show?id=3394101554d7' target=_blank style='color:#2F92EE;'>#骗保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101554, encryptionId=3394101554d7, topicName=骗保)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1d17449116, createdName=zutt, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719706, encodeId=d85e1e1970687, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Sun Jun 09 11:35:00 CST 2019, time=2019-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280448, encodeId=9b511280448eb, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409736, encodeId=5dfc1409e3622, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497206, encodeId=4142149e20631, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587175, encodeId=a386158e17502, content=<a href='/topic/show?id=3394101554d7' target=_blank style='color:#2F92EE;'>#骗保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101554, encryptionId=3394101554d7, topicName=骗保)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1d17449116, createdName=zutt, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719706, encodeId=d85e1e1970687, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Sun Jun 09 11:35:00 CST 2019, time=2019-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280448, encodeId=9b511280448eb, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409736, encodeId=5dfc1409e3622, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497206, encodeId=4142149e20631, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587175, encodeId=a386158e17502, content=<a href='/topic/show?id=3394101554d7' target=_blank style='color:#2F92EE;'>#骗保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101554, encryptionId=3394101554d7, topicName=骗保)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1d17449116, createdName=zutt, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=)]
    2018-12-03 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719706, encodeId=d85e1e1970687, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Sun Jun 09 11:35:00 CST 2019, time=2019-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280448, encodeId=9b511280448eb, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409736, encodeId=5dfc1409e3622, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497206, encodeId=4142149e20631, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587175, encodeId=a386158e17502, content=<a href='/topic/show?id=3394101554d7' target=_blank style='color:#2F92EE;'>#骗保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101554, encryptionId=3394101554d7, topicName=骗保)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1d17449116, createdName=zutt, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1719706, encodeId=d85e1e1970687, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Sun Jun 09 11:35:00 CST 2019, time=2019-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280448, encodeId=9b511280448eb, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409736, encodeId=5dfc1409e3622, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497206, encodeId=4142149e20631, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587175, encodeId=a386158e17502, content=<a href='/topic/show?id=3394101554d7' target=_blank style='color:#2F92EE;'>#骗保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101554, encryptionId=3394101554d7, topicName=骗保)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1d17449116, createdName=zutt, createdTime=Mon Dec 03 05:35:00 CST 2018, time=2018-12-03, status=1, ipAttribution=)]
    2018-12-03 zutt

相关资讯

刚刚!国家医保局大动作将影响全国人民

11月1日上午,国家医疗保障局局长胡静林主持召开局长办公会,审议通过了《国家医疗保障局医疗保障信息平台建设工程实施方案》,并要求按程序尽快开展立项工作。施子海、陈金甫副局长出席会议。会议指出,建设全国统一的医疗保障信息平台,是国家医疗保障局贯彻落实党中央、国务院关于加强医疗保障工作决策部署的重要措施。平台建设坚持问题导向,强化顶层设计,以全国“统筹建设、统一标准、协同共享、安全可靠”为原则,实现全

国家医保局或将年内出台医保支付标准

国家卫健委相关负责人透露,国家医保局组建伊始,其首要职责,并非坊间“恐吓式”传播的“控费”,而是整合医保基金,提高统筹层次,出台医保支付标准,对医疗服务和临床用药实施战略性购买。而由省级卫生部门组织实施的药品集中招标采购,近年来演变的省级限价集中采购,以及各地风起云涌、花样百出的“二次议价”,都将在这一轮医保支付改革,战略性购买模式中“土崩瓦解”。

国家医保局,重磅政策要来

国家医保局接手药品招采,近来动作频频。距离第一份重磅政策,越来越进了。

国家医保局督促推动抗癌药加快降价

近年来,癌症发病率逐年增加,抗癌药“海淘”“代购”成为“热频词”。民之所望,施政所向。国务院采取进口抗癌药零关税等一系列措施,消除流通环节不合理加价:抗癌药关税降为零、减按3%征收进口环节增值税、罕见病用药简化上市要求……记者从国家医疗保障局了解到,随着抗癌药新规逐步落地,各有关部门正积极落实抗癌药降税的后续措施,督促推动抗癌药加快降价,让群众有更多获得感。

央视曝光医院骗保闹剧 透露重大改革信号

“最严监管时代来了!”11月14日,央视《焦点访谈》曝光沈阳两家医院大肆骗保的惊人内幕后,辽宁一家民营医院院长感叹。 据报道,沈阳济华医院、沈阳友好肾病医院两家医院上演了一场“病人是演的、诊断是假的、病房是空的……”的荒诞闹剧。

后天!国家医保局开会,部署国家药品采购

国家医保局主导的药品招标,来了!